Adaptimmune Therapeutics plc

  • Home
  • Our Company
    • Overview arrow_forward
    • Partners arrow_forward
    • Board of Directors arrow_forward
    • Leadership Team arrow_forward
    • Scientific Advisory Board arrow_forward
    • Perspectives arrow_forward
    • COVID-19 arrow_forward
  • Pipeline
    • Overview arrow_forward
    • ADP-A2M4 arrow_forward
    • ADP-A2M4CD8 arrow_forward
    • ADP-A2AFP arrow_forward
    • ADP-A2M10 arrow_forward
  • Technology
    • Overview arrow_forward
    • Manufacturing arrow_forward
    • Publications arrow_forward
  • Patients & Families
    • Overview arrow_forward
    • Taking Part in Our Clincial Trials arrow_forward
    • Cancer Info arrow_forward
    • Cancer Immunotherapy Month arrow_forward
    • Videos arrow_forward
    • Engagement with Patient Organizations arrow_forward
  • Clinical Trials
  • Investors & Media
    • Overview arrow_forward
    • News & Events arrow_forward
    • Annual Shareholder Meeting arrow_forward
    • Company Info arrow_forward
    • Financial Info arrow_forward
    • Stock Data arrow_forward
    • SEC Filings arrow_forward
    • Governance arrow_forward
    • Media arrow_forward
  • Contact
  • Careers
    • Overview arrow_forward
    • US Careers arrow_forward
    • UK Careers arrow_forward

Presentations

Investors & Media

Investors & Media

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Annual Shareholder Meeting
  • Company Info
    • Overview
    • Leadership Team
    • Board of Directors
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Media
  • News & Media

  • Press Releases
  • Presentations
  • Events
April 2021 Corporate Deck
Apr 8, 2021

April 2021 Corporate Deck

March 2021 Corporate Deck
Mar 1, 2021

March 2021 Corporate Deck

February 2021 Corporate Deck
Feb 8, 2021

February 2021 Corporate Deck

39th Annual J.P. Morgan Healthcare Conference Presentation
Jan 14, 2021

39th Annual J.P. Morgan Healthcare Conference Presentation

January 2021 Corporate Deck
Jan 7, 2021

January 2021 Corporate Deck

December 2020 Corporate Deck
Dec 4, 2020

December 2020 Corporate Deck

Investor Day November 2020 Replay
Nov 20, 2020

Investor Day November 2020 Replay

Investor Day November 20, 2020
Nov 20, 2020

Investor Day November 20, 2020

Elliot Norry, Chief Medical Officer – SITC 2020 SURPASS Presentation
Nov 10, 2020

Elliot Norry, Chief Medical Officer – SITC 2020 SURPASS Presentation

SITC 2020 - Adaptimmune's SURPASS Poster
Nov 10, 2020

SITC 2020 - Adaptimmune's SURPASS Poster

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next »
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Adaptimmune Therapeutics plc
Privacy Policy Disclaimer Search Sitemap Terms of Use Supply Terms
Linedin Twitter Youtube
© 2021 Adaptimmune Therapeutics plc. All Rights Reserved.